Institution statistics

SYNAPSE RESEARCH MANAGEMENT PARTNERS SL - Spain 

Ranking results:

Past rankings:
2017
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 19
As coordinator: 1
As participant: 18
Sole participant: 0
Coordinator / Participant Ratio: 0.06*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 1.199.125 23.640.773 2.217.188 1 2
2018 0 18.604.681 1.417.875 2
2017 0 57.199.813 4.050.700 4
2016 0 30.496.261 1.840.250 3
2015 0 3.463.481 275.250 1
2014 0 7.492.000 540.952 2
2013 0 5.984.720 308.800 1
2011 0 2.997.196 264.896 1
2010 0 2.748.319 80.586 1
2008 0 11.889.367 516.929 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM10
JANSSEN PHARMACEUTICA NV6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
ELI LILLY AND COMPANY LIMITED5
F HOFFMANNLA ROCHE5
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE5
NOVARTIS PHARMA5
ALZHEIMER EUROPE4
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT4
THE UNIVERSITY OF EDINBURGH4
ASTRAZENECA AB3
BAYER AKTIENGESELLSCHAFT3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM3
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER3
PFIZER LIMITED3
ST GEORGE'S HOSPITAL MEDICAL SCHOOL3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITEIT LEIDEN3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY OF HELSINKI3
UNIVERSITY OF NEWCASTLE UPON TYNE3
ABBVIE INC2
ACADEMISCH ZIEKENHUIS GRONINGEN2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
DRUG SAFETY RESEARCH TRUST2
EUROPEAN ORGANISATION FOR RARE DISEASES2
EUROPEAN PATIENTS' FORUM2
FONDAZIONE PENTAFOR THE TREATMENT AND CARE OF CHILDREN WITH HIVONLUS2
FONDAZIONE SCIENTIFICA SIMGONLUS2
H LUNDBECK AS2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
KAROLINSKA INSTITUTE2
LEIBNIZINSTITUT FUER PRAEVENTIONSFORSCHUNG UND EPIDEMIOLOGIE BIPS2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
MERCK SHARP & DOHME CORP2
OSPEDALE PEDIATRICO BAMBINO GESU2
PHARMO INSTITUTE NV2
SIMCYP2
STICHTING INFORMATIEVOORZIENING VOOR ZORG EN ONDERZOEK2
STICHTING VU2
STICHTING VUMC2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TARTU ULIKOOL2
UCB BIOPHARMA SPRL2
UNIVERSIDADE DE AVEIRO2
UNIVERSITAET BREMEN2
UNIVERSITAET WIEN2
UNIVERSITY OF BOLOGNA2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF YORK2
AARHUS UNIVERSITETSHOSPITAL1
ABBOTT BIOLOGICALS BV1
ABX CRO ADVANCED PHARMACEUTICAL SERVICES FORSCHUNGSGESELLSCHAFT MBH1
AC IMMUNE1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
AGENZIA ITALIANA DEL FARMACO1
ALEXION SERVICES EUROPE SPRL1
AMGEN LIMITED1
ARISTOTLE UNIVERSITY OF THESSALONIKI1
ASPHALION SL1
ASSOCIATION INTERNATIONALE DE STANDARDISATION BIOLOGIQUE POUR L'EUROPE1
AVERBIS1
BARTS AND THE LONDON NHS TRUST1
BIOBASE1
BIOCOMPUTING PLATFORMS LTD OY1
BIOGEN IDEC LIMITED1
BMD SOFTWARE LDA1
BOEHRINGER INGELHEIM INTERNATIONALGMBH1
BUNDESINSTITUT FUER ARZNEIMITTEL UND MEDIZINPRODUKTE1
CELGENE MANAGEMENT SARL1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CHU HOPITAUX DE BORDEAUX1
CLARIVATE ANALYTICS LIMITED1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONFEDERATION OF MENINGITIS ORGANISATIONS1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
CONSORCIO MAR PARC DE SALUT DE BARCELONA1
CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE1
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH1
COVANCE LABORATORIES1
ELN FOUNDATION1
ETHERNA BVBA1
EUROPAISCHES LABORATORIUM FUER MOLEKULARBIOLOGIE EMBL1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN RESEARCH INITIATIVE ON CLL EV1
EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FONDAZIONE ITALIANA PER LO STUDIO DELLE SINDROMI MIELODISPLASTICHE ONLUS1
FONDAZIONE MARIO NEGRI SUDCENTRO DI RICERCHE FARMACOLOGICHE EB IOMEDICHE1
FONDAZIONE SALVATORE MAUGERI CLINICA DEL LAVORO E DELLA RIABILITAZIONE1
Constancy:

Total number of partners:330

Partner loyalty:
Frequent Partner: (> 2 projects): 90
Rare Partner: 240

Frequent / Rare Partner Ratio: 0.38

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES5
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-03-01Efficiently Networking European Neurodegeneration Research NEURONETcoordinator1.199.1259
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99827
2019-01-01Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe HTxparticipant9.640.77515
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00026
2017-07-01Development of Robust and Innovative Vaccine Effectiveness DRIVEparticipant8.999.81315
2017-01-10Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY HARMONYparticipant20.200.00044
2017-01-10Translational quantitative systems toxicology to improve the understanding of the safety of medicines TransQSTparticipant8.000.00013
2016-12-19REspiratory Syncytial virus Consortium in EUrope RESCEUparticipant14.498.12512
2016-12-08Amyloid imaging to Prevent Alzheimer’s Disease AMYPADparticipant11.999.88612
2016-11-01Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020 ROADMAPparticipant3.998.25026
2015-05-01Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities (MedBioinformatics) MedBioinformaticsparticipant3.463.4819
2014-02-01Treatment of late onset bacterial sepsis caused by vancomycin susceptible bacteria in neonates and infants aged under three months NEOVANCparticipant5.993.00012
2014-01-01Semantic Data Platform for Healthcare SEMCAREparticipant1.499.0005
2013-12-01Therapeutic TriMix / mRNA based Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral Therapy IHIVARNAparticipant5.984.7208
2011-10-01Safety Evaluation of Adverse Reactions in Diabetes SAFEGUARDparticipant2.997.19617
2010-01-01Arrhythmogenic potential of drugs ARITMOparticipant2.748.31920
2008-01-01Genotype-to-phenotype databases: A holistic solution GEN2PHENparticipant11.889.36723
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum